Lessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer

Hiroyuki Yoshida1, Wenjun Cheng1, Jamie Hung1, Denise J. Montell1, Erika R. Geisbrecht1, Daniel Rosen1, Jinsong Liu1, Honami Naora1
1Departments of Molecular Therapeutics, Pathology, and Biochemistry and Molecular Biology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; and Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205

Tóm tắt

Dissemination of ovarian cancer is a major clinical challenge and is poorly understood at the molecular level due to a lack of suitable experimental models. During normal development of the Drosophila ovary, a dynamic process called border cell migration occurs that resembles the migratory behavior of human ovarian cancer cells. In this study, we found that myosin VI, a motor protein that regulates border cell migration, is abundantly expressed in high-grade ovarian carcinomas but not in normal ovary and ovarian cancers that behave indolently. Inhibiting myosin VI expression in high-grade ovarian carcinoma cells impeded cell spreading and migration in vitro . Optical imaging and histopathologic studies revealed that inhibiting myosin VI expression reduces tumor dissemination in nude mice. Therefore, using genetic analysis of border cell migration in Drosophila is a powerful approach to identify novel molecules that promote ovarian cancer dissemination and represent potential therapeutic targets.

Từ khóa


Tài liệu tham khảo

10.3322/canjclin.49.1.8

10.1016/S0925-4773(01)00393-8

10.1038/nrm1006

10.1016/0092-8674(92)90265-E

10.1016/S0092-8674(00)00208-7

10.1002/(SICI)1097-0142(19991015)86:6<1551::AID-CNCR23>3.0.CO;2-P

10.1126/science.277.5328.965

10.1002/cncr.11482

10.1002/(SICI)1097-0215(19981029)78:3<331::AID-IJC13>3.0.CO;2-9

10.1126/science.291.5501.131

10.1038/ncb830

10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5

Lau, D. H., Ross, K. L. & Sikic, B. I. (1990) Cancer Res. 50, 4056–4060.2162251

10.1016/S0002-9440(10)65691-X

10.1007/s004270050145

10.1093/emboj/cdg548

10.1038/46835

10.1038/nrc1075

10.1083/jcb.143.6.1535

10.1034/j.1600-0854.2002.31201.x

10.1038/ncb0902-e211

10.1083/jcb.144.3.533

Birchmeier, W. & Behrens, J. (1994) Biochim. Biophys. Acta 1198, 11–26.8199193

Stefansson, S. & Lawrence, D. A. (2003) Sci. STKE 2003, pe24.12837933

10.1093/emboj/20.14.3676

10.1034/j.1600-0854.2002.30503.x

10.1038/sj.onc.1202649

10.1002/cncr.10870

10.1091/mbc.10.4.819

10.1074/jbc.M203735200

10.1083/jcb.145.4.837

10.1074/jbc.M002138200

10.1016/S0002-9440(10)63458-X

Yoshida, H., Ishiko, O., Sumi, T., Matsumoto, Y. & Ogita, S. (2001) Int. J. Oncol. 19, 537–542.11494033

Byrne, A. T., Ross, L., Holash, J., Nakanishi, M., Hu, L., Hofmann, J. I., Yancopoulos, G. D. & Jaffe, R. B. (2003) Clin. Cancer Res. 9, 5721–5728.14654557

Feldman, G. B., Knapp, R. C., Order, S. E. & Hellman, S. (1972) Cancer Res. 32, 1663–1666.5044130